M. Lepre et al., THE MODULATION OF THE MONOSYNAPTIC REFLEX BY SUBSTANCE-P IN THE HEMISECTED SPINAL-CORD PREPARATION OF THE RAT AND GERBIL, Neuroscience, 55(3), 1993, pp. 727-735
The effects of substance P and the selective neurokinin-I receptor ant
agonist (+/-)-CP-96,345 have been compared on in vitro spinal cord pre
parations from the rat and the gerbil. Substance P produced a concentr
ation-dependent depolarization of motoneurons recorded from ventral ro
ots of both species. The EC50 values (mu M mean +/- S.E.M.) obtained i
n rat (0.95 + 1.0/-0.49) and gerbil (0.47 + 0.26/-0.17) preparations w
ere comparable. The mean maximal depolarization (mV mean +/- S.E.M.) e
voked in rat (2.07 + 0.26/-0.25) was approximately two-fold greater th
an that evoked in gerbil (1.21 + 0.15/-0.14) preparations. In the rat
substance P had a biphasic effect (depression followed by potentiation
) on the short latency probably monosynaptic reflex evoked by electric
al stimulation of a dorsal root. In gerbil preparations substance P pr
oduced only potentiation of the monosynaptic reflex. The EC50 values (
muM mean +/- S.E.M.) for this potentiating action in rat (0.97 + 0.75/
-0.43) and gerbil (0.46+3.6/-0.4) preparations were similar. This pote
ntiation demonstrates a positive modulation of an endogenous excitator
y probably glutamatergic transmission by substance P in the ventral ho
rn of the spinal cord. The depressant phase observed in rat preparatio
ns may be related to the relative immaturity of myelination in rat ven
tral root fibres compared to the gerbil. The selective neurokinin-1 an
tagonist (+/-)-CP-96,345 was one hundred-fold less potent as an antago
nist of substance P-induced depolarizations in the rat (pA2 4.69 +/- 0
.18, n = 7) than in the gerbil (pA2 6.79 +/- 0.16, n = 5) spinal cord.
This finding suggests that (+/-)-CP-96,345 may not act solely at the
neurokinin-1 recognition site. In conclusion this study demonstrates t
hat substance P modulates the monosynaptic reflex in the spinal cord p
resumably via activation of neurokinin-1 receptors.